Análisis de letalidad por COVID-19 en pacientes con demencia neurodegenerativa

INTRODUCTION: The elderly population is the group most threatened by COVID-19, with the highest mortality rates. This study aims to analyse the case fatality of COVID-19 in a cohort of patients with degenerative dementia. METHODS: We conducted a descriptive case-control study of a sample of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Bueno, J.A., Mena-Vázquez, N., Ojea-Ortega, T., Gonzalez-Sotomayor, M.M., Cabezudo-Garcia, P., Ciano-Petersen, N.L., Pons-Pons, G., Castro-Sánchez, M.V., Serrano-Castro, P.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2020
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386259/
http://dx.doi.org/10.1016/j.nrl.2020.07.005
Descripción
Sumario:INTRODUCTION: The elderly population is the group most threatened by COVID-19, with the highest mortality rates. This study aims to analyse the case fatality of COVID-19 in a cohort of patients with degenerative dementia. METHODS: We conducted a descriptive case-control study of a sample of patients diagnosed with primary neurodegenerative dementia. RESULTS: Twenty-four of the 88 patients with COVID-19 included in the study died: 10/23 (43.4%) patients diagnosed with dementia and 14/65 (21.5%) controls; this difference was statistically significant. DISCUSSION: Our results suggest that case fatality of COVID-19 is significantly higher among patients with primary degenerative dementia than in other patients with similar mean ages and comorbidities.

Ejemplares similares